Google’s DeepMind AI identifies kidney patient risk

An AI company owned by Google parent company Alphabet, DeepMind, is able to predict future acute kidney injuries and could potentially save lives, according to new research published in Nature.

Researchers from DeepMind, which is based in London, developed a deep learning approach to predict the deterioration of patients by using acute kidney injury as an exemplar. The model was developed with the records of more than 700,000 patients across 172 inpatient and 1,062 outpatient sites.

The model predicted more than half––55.8%––of all inpatient episodes of acute kidney injury and 90.2% of all acute kidney injuries that required dialysis. The lead up time was 48 hours and the model had a ratio of two false alerts for every true alert.

Despite this, the system was still 20% more accurate than an existing prediction model that assesses the likelihood of kidney injury, according to the authors.

The findings have implications for saving lives in hospitals, as 11% of all deaths in hospitals come from a failure to recognize and treat deteriorating patients.

“Although the recognition and prompt treatment of acute kidney injury is known to be challenging, our approach may offer opportunities for identifying patients at risk within a time window that enables early treatment,” lead author Nenad Tomasev, from DeepMind in London, et al. wrote.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”